HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sochman, J. Search for Related Content PubMed PubMed Citation Articles by Sochman, J.

REVIEW ARTICLE

N-acetylcysteine in acute cardiology: 10 years later

What do we know and what would we like to know?!

^* Institute for Clinical and Experimental Medicine, Prague, Czech Republic

Manuscript received April 16, 2001; revised manuscript received January 17, 2002, accepted February 8, 2002.

^* Reprint requests and correspondence: Dr. Jan Sochman, Intensive Care Unit, Institute for Clinical and Experimental Medicine, Videnska 1958/9, 140 21 Prague 4, Czech Republic.
jan.sochman{at}medicon.cz

N-acetylcysteine (NAC) is known in a variety of branches of medicine. This paper addresses in detail the action of NAC as it is emerging from research and clinical trials over the past decade in cardiology, giving rise to new concepts. The result is a process resembling creation of a mosaic from individual pieces. Also, the role of NAC in acute cardiology, during acute reperfusion in particular, is defined.

Abbreviations and Acronyms   GISSI   Gruppo Italiano per lo Studio della Streptochinasi nell’ Infarto Miocardico study   GUSTO   Global Utilization of Streptokinase and T-PA for Occluded Coronary Artery trial   ISIS   International Study of Infarct Survival   ISLAND   Infarct Size Limitation: Acute N-acetylcysteine Defense trial   MPG   mercaptopropionyl glycine   NAC   N-acetylcysteine   -SH   sulfhydryl groups

This article has been cited by other articles:

				I. El-Hamamsy, L.-M. Stevens, M. Carrier, M. Pellerin, D. Bouchard, P. Demers, R. Cartier, P. Page, and L. P. Perrault Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: A randomized, double-blind, placebo-controlled clinical trial J. Thorac. Cardiovasc. Surg., January 1, 2007; 133(1): 7 - 12. [Abstract] [Full Text] [PDF]

				P. V. Usatyuk, N. L. Parinandi, and V. Natarajan Redox Regulation of 4-Hydroxy-2-nonenal-mediated Endothelial Barrier Dysfunction by Focal Adhesion, Adherens, and Tight Junction Proteins J. Biol. Chem., November 17, 2006; 281(46): 35554 - 35566. [Abstract] [Full Text] [PDF]

				M. Bourraindeloup, C. Adamy, G. Candiani, M. Cailleret, M.-C. Bourin, T. Badoual, J. B. Su, S. Adubeiro, F. Roudot-Thoraval, J.-L. Dubois-Rande, et al. N-Acetylcysteine Treatment Normalizes Serum Tumor Necrosis Factor-{alpha} Level and Hinders the Progression of Cardiac Injury in Hypertensive Rats Circulation, October 5, 2004; 110(14): 2003 - 2009. [Abstract] [Full Text] [PDF]

				K. Robinson Renal Disease, Homocysteine, and Cardiovascular Complications Circulation, January 27, 2004; 109(3): 294 - 295. [Full Text] [PDF]

				M. Cailleret, A. Amadou, N. Andrieu-Abadie, A. Nawrocki, C. Adamy, B. Ait-Mamar, F. Rocaries, M. Best-Belpomme, T. Levade, C. Pavoine, et al. N-Acetylcysteine Prevents the Deleterious Effect of Tumor Necrosis Factor-{alpha} on Calcium Transients and Contraction in Adult Rat Cardiomyocytes Circulation, January 27, 2004; 109(3): 406 - 411. [Abstract] [Full Text] [PDF]